#ns5 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #ns5, aggregated by home.social.
-
Sporadic Occurrence of #Ensitrelvir #Resistant #SarsCoV2 #Japan, Emerg Infect Dis.: https://wwwnc.cdc.gov/eid/article/30/6/24-0023_article
Using the GISAID EpiCoV database, we identified 256 #COVID19 patients in Japan during March 31–December 31, 2023, who had mutations in the SARS-CoV-2 #NS5 conferring ensitrelvir resistance.
-
Sporadic Occurrence of #Ensitrelvir #Resistant #SarsCoV2 #Japan, Emerg Infect Dis.: https://wwwnc.cdc.gov/eid/article/30/6/24-0023_article
Using the GISAID EpiCoV database, we identified 256 #COVID19 patients in Japan during March 31–December 31, 2023, who had mutations in the SARS-CoV-2 #NS5 conferring ensitrelvir resistance.
-
Sporadic Occurrence of #Ensitrelvir #Resistant #SarsCoV2 #Japan, Emerg Infect Dis.: https://wwwnc.cdc.gov/eid/article/30/6/24-0023_article
Using the GISAID EpiCoV database, we identified 256 #COVID19 patients in Japan during March 31–December 31, 2023, who had mutations in the SARS-CoV-2 #NS5 conferring ensitrelvir resistance.
-
Sporadic Occurrence of #Ensitrelvir #Resistant #SarsCoV2 #Japan, Emerg Infect Dis.: https://wwwnc.cdc.gov/eid/article/30/6/24-0023_article
Using the GISAID EpiCoV database, we identified 256 #COVID19 patients in Japan during March 31–December 31, 2023, who had mutations in the SARS-CoV-2 #NS5 conferring ensitrelvir resistance.
-
Sporadic Occurrence of #Ensitrelvir #Resistant #SarsCoV2 #Japan, Emerg Infect Dis.: https://wwwnc.cdc.gov/eid/article/30/6/24-0023_article
Using the GISAID EpiCoV database, we identified 256 #COVID19 patients in Japan during March 31–December 31, 2023, who had mutations in the SARS-CoV-2 #NS5 conferring ensitrelvir resistance.